Skip to main content

Main menu

  • Home
  • Content
    • Current Issue
    • Past Issues
    • Accepted Articles
    • Email Alerts
    • RSS
    • Terms of Use
  • About PDA JPST
    • JPST Editors and Editorial Board
    • About/Vision/Mission
    • Paper of the Year
  • Author & Reviewer Resources
    • Author Resources / Submit
    • Reviewer Resources
  • JPST Access and Subscriptions
    • PDA Members
    • Institutional Subscriptions
    • Nonmember Access
  • Support
    • Join PDA
    • Contact
    • Feedback
    • Advertising
    • CiteTrack
  • .
    • Visit PDA
    • PDA Letter
    • Technical Reports
    • news uPDATe
    • Bookstore

User menu

  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
PDA Journal of Pharmaceutical Science and Technology
  • .
    • Visit PDA
    • PDA Letter
    • Technical Reports
    • news uPDATe
    • Bookstore
  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart
PDA Journal of Pharmaceutical Science and Technology

Advanced Search

  • Home
  • Content
    • Current Issue
    • Past Issues
    • Accepted Articles
    • Email Alerts
    • RSS
    • Terms of Use
  • About PDA JPST
    • JPST Editors and Editorial Board
    • About/Vision/Mission
    • Paper of the Year
  • Author & Reviewer Resources
    • Author Resources / Submit
    • Reviewer Resources
  • JPST Access and Subscriptions
    • PDA Members
    • Institutional Subscriptions
    • Nonmember Access
  • Support
    • Join PDA
    • Contact
    • Feedback
    • Advertising
    • CiteTrack
  • Follow pda on Twitter
  • Visit PDA on LinkedIn
  • Visit pda on Facebook
Article CommentaryCommentary

Enabling ICH Q10 Implementation—Part 1. Striving for Excellence by Embracing ICH Q8 and ICH Q9

Nuala Calnan, Kevin O'Donnell and Anne Greene
PDA Journal of Pharmaceutical Science and Technology November 2013, 67 (6) 581-600; DOI: https://doi.org/10.5731/pdajpst.2013.00940
Nuala Calnan
1School of Chemical and Pharmaceutical Science, Dublin Institute of Technology, Dublin, Ireland; and
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: nuala.calnan@mydit.ie
Kevin O'Donnell
2Irish Medicines Board, Bord Leigheasra na hÉireann, Dublin, Ireland
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Anne Greene
1School of Chemical and Pharmaceutical Science, Dublin Institute of Technology, Dublin, Ireland; and
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • References
  • Info & Metrics
  • PDF
Loading

Article Information

vol. 67 no. 6 581-600
DOI 
https://doi.org/10.5731/pdajpst.2013.00940
PubMed 
24265300

Published By 
Parenteral Drug Association (PDA)
Print ISSN 
1079-7440
Online ISSN 
1948-2124
History 
  • Published online November 21, 2013.

Copyright & Usage 
© PDA, Inc. 2013

Author Information

  1. Nuala Calnan1,*,
  2. Kevin O'Donnell2 and
  3. Anne Greene1
  1. 1School of Chemical and Pharmaceutical Science, Dublin Institute of Technology, Dublin, Ireland; and
  2. 2Irish Medicines Board, Bord Leigheasra na hÉireann, Dublin, Ireland
  1. ↵*Corresponding Author: Nuala Calnan, Regulatory Science Researcher, Pharmaceutical Regulatory Science Team (PRST), School of Chemical & Pharmaceutical Sciences, Dublin Institute of Technology, Kevin Street, Dublin, Ireland. Telephone: +353 87 978 6968, E-mail: nuala.calnan{at}mydit.ie
View Full Text

Cited By...

  • 3 Citations
  • Google Scholar

This article has been cited by the following articles in journals that are participating in Crossref Cited-by Linking.

  • A Systematic Review of Teachers’ Causal Attributions: Prevalence, Correlates, and Consequences
    Hui Wang, Nathan C. Hall
    Frontiers in Psychology 2018 9
  • Quality by Design (QbD) application for the pharmaceutical development process
    Sang-Ho Lee, Jin-Ki Kim, Jun-Pil Jee, Dong-Jin Jang, Young-Joon Park, Joo-Eun Kim
    Journal of Pharmaceutical Investigation 2022 52 6
  • Scavenger receptor SRA attenuates TLR4-induced microglia activation in intracerebral hemorrhage
    Bangqing Yuan, Hanchao Shen, Li Lin, Tonggang Su, Zemin Huang, Zhao Yang
    Journal of Neuroimmunology 2015 289
PreviousNext
Back to top

In This Issue

PDA Journal of Pharmaceutical Science and Technology: 67 (6)
PDA Journal of Pharmaceutical Science and Technology
Vol. 67, Issue 6
November/December 2013
  • Table of Contents
  • Index by Author
Print
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on PDA Journal of Pharmaceutical Science and Technology.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Enabling ICH Q10 Implementation—Part 1. Striving for Excellence by Embracing ICH Q8 and ICH Q9
(Your Name) has sent you a message from PDA Journal of Pharmaceutical Science and Technology
(Your Name) thought you would like to see the PDA Journal of Pharmaceutical Science and Technology web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
4 + 11 =
Solve this simple math problem and enter the result. E.g. for 1+3, enter 4.
Citation Tools
Enabling ICH Q10 Implementation—Part 1. Striving for Excellence by Embracing ICH Q8 and ICH Q9
Nuala Calnan, Kevin O'Donnell, Anne Greene
PDA Journal of Pharmaceutical Science and Technology Nov 2013, 67 (6) 581-600; DOI: 10.5731/pdajpst.2013.00940

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Enabling ICH Q10 Implementation—Part 1. Striving for Excellence by Embracing ICH Q8 and ICH Q9
Nuala Calnan, Kevin O'Donnell, Anne Greene
PDA Journal of Pharmaceutical Science and Technology Nov 2013, 67 (6) 581-600; DOI: 10.5731/pdajpst.2013.00940
Twitter logo Facebook logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • Abstract
    • 1 Introduction
    • 2 Pharmaceutical Quality System (PQS) Implementation within Commercial Manufacturing
    • 3 Conclusion: What Are the Benefits?
    • Conflict of Interest Declaration
    • References
  • Figures & Data
  • References
  • Info & Metrics
  • PDF

Related Articles

  • No related articles found.
  • PubMed
  • Google Scholar

Cited By...

  • No citing articles found.
  • Google Scholar

More in this TOC Section

  • Challenges and Solutions to Manufacturing of Low-Viscosity, Ultra-High Concentration IgG1 Drug Products: From Late Downstream Process to Final Fill Finish Processing
  • Retrospective Evaluation of Cycled Resin in Viral Clearance Studies - A Multiple Company Collaboration - Post ICH Q5A(R2) Review
  • Addressing Medical Device Extractables and Leachables via Non-Target Analysis (NTA); The Analytical Evaluation Threshold (AET) and Quantitation
Show more Commentary

Similar Articles

Keywords

  • The International Conference on Harmonisation of Technical Requirements for Registration of Pharmaceuticals for Human Use (ICH)
  • ICH Q8 (R2) Product Development
  • ICH Q9 Quality Risk Management (QRM)
  • ICH Q10 Pharmaceutical Quality System (PQS)
  • Implementation
  • Operational excellence
  • Six sigma
  • Lean manufacturing
  • innovation
  • Continual improvement
  • Senior and corporate management responsibilities
  • Leadership
  • Regional regulatory enforcement
  • Knowledge creation and management.

Readers

  • About
  • Table of Content Alerts/Other Alerts
  • Subscriptions
  • Terms of Use
  • Contact Editors

Author/Reviewer Information

  • Author Resources
  • Submit Manuscript
  • Reviewers
  • Contact Editors

Parenteral Drug Association, Inc.

  • About
  • Advertising/Sponsorships
  • Events
  • PDA Bookstore
  • Press Releases

© 2025 PDA Journal of Pharmaceutical Science and Technology Print ISSN: 1079-7440  Digital ISSN: 1948-2124

Powered by HighWire